Sore throat: justification of the optimal drug selection
https://doi.org/10.21518/2079-701X-2016-18-128-132
Abstract
Sore throat is one of the most frequent complaints that doctors of various specialties face. About 80% of diseases a symptom of which might be sore throat and throat irritation is acute pharyngitis or acute tonsillitis developing on the background of SARS [6].
About the Authors
A. N. Slavsky
Sechenov First Moscow State Medical University
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
I. Y. Meytel
Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
References
1. Košir P. A comparison of therapeutic equivalence between test and reference formulations of the fixed combination of 3 milligrams benzydamine hydrochloride and 1 milligram cetylpyridinium chloride in the treatment of sore throat associated with upper respiratory tract infections. Med Razgl, 2015, 54 (Suppl 3): 433-42.
2. Košir P. Clinical experience with Septolete plus products in the treatment of sore throat. Krka Med Farm, 2014, 26(38): 136-143.
3. Final report. A cjmparative study of the efficacy and safety of Septolete plus oromucosal spray 1.5 mg +0.3 mg/dose in subjects with sore throat associated with the reference product TheraFlu LAR, Phase III study.
4. Zabolotnyy DI et al. Treating of chronic pharyngitis at the stage of aggravation: clinical, immunological and microbiological aspects. Zdorovja Ukraini. The Medical Journal, 2007, 19(176): 1-3.
5. Крюков А.И. Этиотропная и патогенетическая терапия болевого синдрома в ротоглотке. Медицинский совет, 2015, 3.
6. Лучшева Ю.В., Изотова Г.Н. Местная терапия при фарингите. РМЖ, 2011, 19(6): 20-23.
Review
For citations:
Slavsky AN, Meytel IY. Sore throat: justification of the optimal drug selection. Meditsinskiy sovet = Medical Council. 2016;(18):128-132. (In Russ.) https://doi.org/10.21518/2079-701X-2016-18-128-132
Views:
851
Email this article 